Hurtsellers Christine
Transaction: 05/06/2026
BUY
Change
+748
Price
$13.36
Filing
05/07/2026
Type
BUY
John Hancock Investors Trust
JHI • Asset Management
$11.91
▼ -0.05 (-0.42%)
Current price
EarningsLatest report: Oct 31, 2025
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$104.32M
Growth
-1.9%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 68.3%Positive free cash flow · 1.07Consistent free cash flow · 5/5Reasonable earnings multiple · 11.93Manageable debt level · 0.67
Financial data as of: Oct 31, 2025, 12:00 AM UTCLast earnings update: Oct 31, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$11.91
Change-0.42%
Shares Out8.74M
Market Cap$104.32M
Enterprise Value$190.98M
52W Range12.50 - 14.51
Beta0.71
P/E3.38
P/S3.56
P/B0.80
P/FCF5.57
EV/Sales6.52
Price$11.91
Change-0.42%
Shares Out8.74M
Market Cap$104.32M
Enterprise Value$190.98M
52W Range12.50 - 14.51
Beta0.71
P/E3.38
P/S3.56
P/B0.80
P/FCF5.57
EV/Sales6.52
EV/EBITDA15.71
EV/FCF10.19
Earnings Yield29.56%
FCF Yield17.97%
Dividend Yield18.42%
Gross Margin69.98%
Oper. Margin68.30%
Profit Margin68.30%
Debt/Eq0.67
Current Ratio1.15
Quick Ratio1.15
Revenue 5Y-1.90%
FCF 5Y-2.53%
Volume5.48K
Avg Volume19.17K
Investment DNA
How strong this company looks for long-term investors
69
out of 100
Business Quality
Margins, moat, returns
85/100
Financial Strength
Debt, cash, stability
59/100
Growth Potential
Revenue and expansion
25/100
Price Attractiveness
Cheap or expensive today
70/100
Why this score▼
Stable or improving margins · 68.3%Positive free cash flow · 1.07Consistent free cash flow · 5/5Reasonable earnings multiple · 11.93Manageable debt level · 0.67Negative growth trend
Analyst view
No analyst data available now.
Insider Transactions
Recent executive and insider activity
Phelan Kenneth J
Transaction: 01/27/2026
BUY
Change
+730
Price
$13.75
Filing
01/27/2026
Type
BUY
Phelan Kenneth J
Transaction: 11/12/2025
OTHER
Change
0
Price
Not reported
Filing
11/17/2025
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Hurtsellers Christine | BUY | +748 | $13.36 | 05/06/2026 | 05/07/2026 |
| Phelan Kenneth J | BUY | +730 | $13.75 | 01/27/2026 | 01/27/2026 |
| Phelan Kenneth J | OTHER | 0 | Not reported | 11/12/2025 | 11/17/2025 |
| Hurtsellers Christine | OTHER | 0 | Not reported | 11/12/2025 | 11/17/2025 |
| Georgountzos Effie | OTHER | 0 | Not reported | 06/16/2025 | 07/31/2025 |
| Wright Thomas Rowe | BUY | +875 | $12.57 | 04/08/2025 | 04/09/2025 |
| Bacic William K | BUY | +719 | $14.00 | 01/14/2025 | 01/15/2025 |
| Ellison Noni L | BUY | +600 | $14.10 | 12/23/2024 | 12/26/2024 |
| Nataupsky Jeff | OTHER | 0 | Not reported | 10/31/2024 | 11/06/2024 |
| Carrington Patricia | OTHER | 0 | Not reported | 09/26/2024 | 10/02/2024 |
| Bacic William K | OTHER | 0 | Not reported | 08/01/2024 | 08/08/2024 |
| Wright Thomas Rowe | OTHER | 0 | Not reported | 08/01/2024 | 08/08/2024 |
| Silva Fernando A | OTHER | 0 | Not reported | 07/01/2024 | 07/02/2024 |
| McCubbin Terence A | OTHER | 0 | Not reported | 05/13/2024 | 05/15/2024 |
| Garfield Dean | BUY | — | $14.41 | 01/02/2024 | 01/04/2024 |
| Ellison Noni L | BUY | +925 | $11.93 | 10/12/2023 | 10/16/2023 |
| McFetridge Andy | OTHER | 0 | Not reported | 10/06/2023 | 10/10/2023 |
| Feinberg Kristie | OTHER | 0 | Not reported | 05/16/2023 | 05/23/2023 |
| Lo York | OTHER | 0 | Not reported | 12/15/2022 | 12/23/2022 |
| PRUCHANSKY STEVEN R | SELL | — | $14.47 | 08/05/2022 | 08/09/2022 |